The Impact of Tumor Volume Burden Reduction for Pediatric Solid Tumors by Immune Checkpoint Inhibitors

被引：0
|
作者：
Saito, Takeshi [1 ,2 ]
Fuchimoto, Yasushi [2 ]
Fukui, Keisuke [2 ]
Shimizu, Takahiro [3 ]
Kuroda, Tatsuo [4 ]
Hirabayashi, Takeshi [1 ]
Hakamada, Kenichi [1 ]
机构：
[1] Hirosaki Univ Hosp, Dept Pediat Surg, Aomori, Japan
[2] Int Univ Hlth & Welf Hosp, Dept Pediat Surg, Otawara, Tochigi, Japan
[3] Tokai Univ, Sch Med, Dept Pediat Surg, Hiratsuka, Kanagawa, Japan
[4] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS35-3-4
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment
    Khan, Uqba
    Ho, Kaylee
    Hwang, Eun Kyeong
    Pena, Cristian
    Brouwer, Julianna
    Hoffman, Katherine
    Betel, Doron
    Sonnenberg, Gregory F.
    Faltas, Bishoy
    Saxena, Ashish
    Weisiger, Kaitlin Eng
    Oh, Sarah
    Hissong, Erika
    RoyChoudhury, Arindam
    Shah, Manish A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (06): : 247 - 253
  • [42] Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors
    Smith, Katherine E. R.
    Markovic, Svetomir N.
    CLINICAL CHEMISTRY, 2024, 70 (01) : 25 - 26
  • [43] High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
    Vareki, Saman Maleki
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [44] Immune Checkpoint Inhibitors in Progressive Neuroendocrine Tumors
    Chauhan, Aman
    Anthony, Lowell
    PANCREAS, 2018, 47 (03) : 335 - 335
  • [45] Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors
    Zhang, Xin
    Li, Huiqin
    Lv, Xiupeng
    Hu, Li
    Li, Wen
    Zi, Meiting
    He, Yonghan
    LIFE-BASEL, 2022, 12 (03):
  • [46] The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
    Koustas, Evangelos
    Sarantis, Panagiotis
    Papavassiliou, Athanasios G.
    Karamouzis, Michalis V.
    BIOMOLECULES, 2020, 10 (05)
  • [47] Tumour burden and efficacy of immune-checkpoint inhibitors
    Dall'Olio, Filippo G.
    Marabelle, Aurelien
    Caramella, Caroline
    Garcia, Camilo
    Aldea, Mihaela
    Chaput, Nathalie
    Robert, Caroline
    Besse, Benjamin
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) : 75 - 90
  • [48] Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
    Nassar, Amin H.
    El Zarif, Talal
    Khalid, Ahmed Bilal
    Rahme, Serena
    Zhong, Caiwei
    Kwak, Lucia
    Salame, Marita
    Farhat, Elias Bou
    Freeman, Dory
    El-Am, Edward
    Ravishankar, Arjun
    Ahmad, Bachar
    Nana, Frank Aboubakar
    Kaldas, David
    Naqash, Abdul Rafeh
    Sharon, Elad
    LeBoeuf, Nicole R.
    Cortellini, Alessio
    Malgeri, Andrea
    Gupta, Shruti
    Al-Hader, Ahmad
    Sparks, Jeffrey A.
    Linnoila, Jenny
    Hamnvik, Ole-Petter R.
    Mouhieddine, Tarek H.
    Marron, Thomas
    Parikh, Kaushal
    McKay, Rana R.
    Dilling, Thomas
    Choueiri, Toni K.
    Adib, Elio
    Najem, Elie
    Kim, So Yeon
    Sonpavde, Guru
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
  • [49] Prevalence of prkdc mutations and association with response to immune checkpoint inhibitors in solid tumors.
    Li, Yi
    Chen, Chuan-ben
    Chen, Yu
    Guan, Yan-Fang
    Huang, Yingying
    Lin, Jing
    Chen, Gang
    Xia, Xuefeng
    Chang, Lianpeng
    Yi, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] A real-world data of Immune checkpoint inhibitors in solid tumors from India
    Noronha, Vanita
    Abraham, George
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Jain, Srushti
    Talreja, Vikas T.
    Kapoor, Akhil
    Singh, Gunjesh Kumar
    Khaddar, Satvik
    Gupta, Kushal
    Rathinasamy, Narmadha
    Srinivas, Sujay
    Agrawal, Amit
    Ventrapati, Pradeep
    Prabhash, Kumar
    CANCER MEDICINE, 2021, 10 (05): : 1525 - 1534
12345